mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.001 |